Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sirtuins | 5 | 2021 | 322 | 0.470 |
Why?
|
Neuroblastoma | 5 | 2022 | 1266 | 0.380 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2023 | 8621 | 0.310 |
Why?
|
Gene Expression Profiling | 23 | 2017 | 9525 | 0.300 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 635 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2017 | 2456 | 0.230 |
Why?
|
Cell Line, Tumor | 24 | 2023 | 17088 | 0.220 |
Why?
|
Zebrafish Proteins | 2 | 2020 | 1018 | 0.210 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2013 | 776 | 0.210 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2023 | 1609 | 0.200 |
Why?
|
Neurofibromin 1 | 2 | 2020 | 190 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2948 | 0.190 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Cell Differentiation | 13 | 2019 | 11651 | 0.190 |
Why?
|
Glutamine | 1 | 2023 | 575 | 0.180 |
Why?
|
Neurofibrosarcoma | 1 | 2020 | 28 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3636 | 0.170 |
Why?
|
Ants | 2 | 2010 | 32 | 0.170 |
Why?
|
RNA-Binding Proteins | 2 | 2020 | 1884 | 0.160 |
Why?
|
Sarcoma, Experimental | 1 | 2019 | 116 | 0.160 |
Why?
|
Genes, ras | 2 | 2018 | 656 | 0.150 |
Why?
|
Receptor, Notch1 | 2 | 2013 | 518 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2023 | 2839 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 465 | 0.150 |
Why?
|
Haploinsufficiency | 1 | 2020 | 334 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2019 | 658 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 7 | 2020 | 5690 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 3 | 2010 | 422 | 0.140 |
Why?
|
ras Proteins | 2 | 2020 | 1055 | 0.140 |
Why?
|
Transcription Factors | 7 | 2020 | 12150 | 0.140 |
Why?
|
Glycolysis | 1 | 2021 | 838 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5329 | 0.140 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 230 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 3 | 2019 | 4522 | 0.130 |
Why?
|
Cell Survival | 8 | 2015 | 5748 | 0.130 |
Why?
|
Gene Expression | 7 | 2018 | 7585 | 0.130 |
Why?
|
Cell Proliferation | 11 | 2023 | 10445 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2015 | 3796 | 0.130 |
Why?
|
Histone Deacetylase 2 | 2 | 2013 | 71 | 0.130 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2018 | 309 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2014 | 2060 | 0.130 |
Why?
|
Acetylation | 5 | 2019 | 1054 | 0.130 |
Why?
|
Histone Deacetylase 1 | 2 | 2013 | 133 | 0.120 |
Why?
|
RNA Polymerase II | 1 | 2019 | 549 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 802 | 0.120 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2016 | 134 | 0.120 |
Why?
|
Mice, SCID | 6 | 2020 | 2628 | 0.120 |
Why?
|
Head and Neck Neoplasms | 2 | 2021 | 2929 | 0.120 |
Why?
|
Zebrafish | 3 | 2020 | 3035 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 582 | 0.110 |
Why?
|
Neoplasms | 7 | 2023 | 22350 | 0.110 |
Why?
|
Gene Silencing | 1 | 2020 | 1504 | 0.110 |
Why?
|
Cytosine | 1 | 2015 | 212 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2014 | 129 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2021 | 3607 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2885 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1351 | 0.100 |
Why?
|
Transcriptional Activation | 1 | 2018 | 1749 | 0.100 |
Why?
|
Lactams | 1 | 2013 | 159 | 0.100 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 132 | 0.100 |
Why?
|
Mutant Proteins | 1 | 2014 | 487 | 0.100 |
Why?
|
Mice | 22 | 2021 | 81889 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2008 | 1331 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2013 | 2426 | 0.100 |
Why?
|
RNA Interference | 7 | 2017 | 2827 | 0.100 |
Why?
|
Animals | 30 | 2021 | 168930 | 0.100 |
Why?
|
Receptors, Androgen | 3 | 2006 | 1089 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2016 | 9611 | 0.090 |
Why?
|
Signal Transduction | 11 | 2020 | 23619 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1895 | 0.090 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2016 | 723 | 0.090 |
Why?
|
Retinoblastoma Protein | 1 | 2015 | 670 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13643 | 0.090 |
Why?
|
Adenocarcinoma | 4 | 2020 | 6359 | 0.090 |
Why?
|
Animals, Genetically Modified | 3 | 2020 | 1562 | 0.090 |
Why?
|
Trans-Activators | 1 | 2020 | 2855 | 0.090 |
Why?
|
Pancreatic Neoplasms | 3 | 2020 | 5444 | 0.090 |
Why?
|
Benzodioxoles | 1 | 2010 | 80 | 0.090 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2012 | 414 | 0.080 |
Why?
|
Light | 1 | 2016 | 1358 | 0.080 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 454 | 0.080 |
Why?
|
Lysosomes | 1 | 2015 | 937 | 0.080 |
Why?
|
Leukemia | 2 | 2020 | 1521 | 0.080 |
Why?
|
Actins | 1 | 2016 | 2060 | 0.080 |
Why?
|
Purines | 2 | 2010 | 615 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2013 | 718 | 0.080 |
Why?
|
Cell Lineage | 2 | 2015 | 2572 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.080 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2009 | 136 | 0.080 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 562 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 614 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1751 | 0.080 |
Why?
|
Melanoma | 3 | 2017 | 5700 | 0.070 |
Why?
|
Mutation | 9 | 2020 | 30213 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5789 | 0.070 |
Why?
|
Retinoids | 1 | 2008 | 99 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1243 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2014 | 950 | 0.070 |
Why?
|
Histones | 5 | 2019 | 2593 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11920 | 0.070 |
Why?
|
Chromatin | 1 | 2019 | 2977 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2016 | 2448 | 0.070 |
Why?
|
Genes, Insect | 1 | 2008 | 265 | 0.070 |
Why?
|
HL-60 Cells | 4 | 2012 | 365 | 0.070 |
Why?
|
Quinazolines | 3 | 2015 | 1367 | 0.070 |
Why?
|
Autophagy | 1 | 2015 | 1346 | 0.070 |
Why?
|
Janus Kinase 2 | 1 | 2010 | 562 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1246 | 0.070 |
Why?
|
Insect Proteins | 1 | 2008 | 253 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1621 | 0.070 |
Why?
|
RNA, Messenger | 7 | 2014 | 12791 | 0.070 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 355 | 0.070 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 104 | 0.070 |
Why?
|
Galectin 3 | 1 | 2008 | 239 | 0.070 |
Why?
|
Genomics | 4 | 2012 | 5923 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2902 | 0.070 |
Why?
|
Humans | 51 | 2023 | 766766 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2020 | 21162 | 0.060 |
Why?
|
Dihydrotestosterone | 1 | 2006 | 194 | 0.060 |
Why?
|
RNA-Binding Protein EWS | 2 | 2023 | 211 | 0.060 |
Why?
|
Cytarabine | 1 | 2007 | 696 | 0.060 |
Why?
|
Biological Evolution | 1 | 2010 | 1075 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 4570 | 0.060 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2004 | 111 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2015 | 2012 | 0.060 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 616 | 0.060 |
Why?
|
Cyclins | 1 | 2006 | 605 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2015 | 1757 | 0.060 |
Why?
|
Prostatic Neoplasms | 5 | 2007 | 11094 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3666 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2005 | 327 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2660 | 0.050 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 646 | 0.050 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18330 | 0.050 |
Why?
|
Mice, Inbred NOD | 3 | 2014 | 1838 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 996 | 0.050 |
Why?
|
RNA, Small Interfering | 4 | 2017 | 3425 | 0.050 |
Why?
|
Glutamates | 1 | 2023 | 384 | 0.050 |
Why?
|
Transcription, Genetic | 5 | 2015 | 7609 | 0.050 |
Why?
|
Proline | 1 | 2023 | 454 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2016 | 7868 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9404 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 313 | 0.050 |
Why?
|
Social Behavior | 1 | 2008 | 1147 | 0.050 |
Why?
|
Apoptosis | 5 | 2019 | 9513 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 11872 | 0.050 |
Why?
|
Disease Progression | 4 | 2021 | 13640 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1377 | 0.050 |
Why?
|
Erythropoiesis | 2 | 2019 | 692 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2014 | 4891 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2021 | 14471 | 0.050 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2016 | 630 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4049 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2009 | 1086 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2004 | 695 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1604 | 0.040 |
Why?
|
Mice, Nude | 2 | 2017 | 3616 | 0.040 |
Why?
|
Cell Line | 5 | 2019 | 15563 | 0.040 |
Why?
|
U937 Cells | 2 | 2012 | 260 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18075 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 126 | 0.040 |
Why?
|
Proteomics | 2 | 2015 | 3914 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2005 | 732 | 0.040 |
Why?
|
Transfection | 3 | 2015 | 5754 | 0.040 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3824 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9244 | 0.040 |
Why?
|
Protein Kinases | 1 | 2006 | 1610 | 0.040 |
Why?
|
bcl-X Protein | 2 | 2015 | 412 | 0.040 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2020 | 252 | 0.040 |
Why?
|
Genome, Human | 3 | 2006 | 4443 | 0.040 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2015 | 257 | 0.040 |
Why?
|
Flow Cytometry | 4 | 2013 | 5890 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2534 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1280 | 0.040 |
Why?
|
Heterozygote | 2 | 2020 | 2795 | 0.040 |
Why?
|
Glutathione | 1 | 2021 | 589 | 0.040 |
Why?
|
Globins | 1 | 2019 | 405 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 747 | 0.040 |
Why?
|
Genotype | 4 | 2015 | 13036 | 0.040 |
Why?
|
Transcriptional Elongation Factors | 1 | 2019 | 169 | 0.040 |
Why?
|
Molecular Structure | 2 | 2016 | 1882 | 0.040 |
Why?
|
Tumor Cells, Cultured | 3 | 2013 | 6104 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 2 | 2009 | 464 | 0.040 |
Why?
|
Phosphorylation | 3 | 2014 | 8307 | 0.040 |
Why?
|
Anoikis | 1 | 2017 | 49 | 0.030 |
Why?
|
Carboxy-Lyases | 1 | 2017 | 85 | 0.030 |
Why?
|
Peptide Synthases | 1 | 2017 | 81 | 0.030 |
Why?
|
Limonins | 2 | 2006 | 25 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2017 | 182 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 401 | 0.030 |
Why?
|
Gene Amplification | 2 | 2014 | 1088 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5387 | 0.030 |
Why?
|
Aneuploidy | 1 | 2020 | 573 | 0.030 |
Why?
|
Retroviridae | 1 | 2018 | 846 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 803 | 0.030 |
Why?
|
Estrogens | 2 | 2017 | 1528 | 0.030 |
Why?
|
Azo Compounds | 1 | 2016 | 115 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4410 | 0.030 |
Why?
|
Female | 15 | 2021 | 396520 | 0.030 |
Why?
|
Extracellular Space | 1 | 2017 | 563 | 0.030 |
Why?
|
Small Molecule Libraries | 2 | 2013 | 740 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 6222 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 945 | 0.030 |
Why?
|
Testosterone | 1 | 2006 | 2495 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
Enzyme Inhibitors | 3 | 2013 | 3721 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2015 | 146 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2007 | 2561 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1142 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 367 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2823 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2015 | 220 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2017 | 697 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1405 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9547 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2221 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2014 | 186 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 432 | 0.030 |
Why?
|
Cell Division | 2 | 2014 | 4474 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2014 | 125 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 2014 | 228 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 283 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22352 | 0.030 |
Why?
|
Thapsigargin | 1 | 2013 | 102 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1671 | 0.030 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2014 | 303 | 0.030 |
Why?
|
Dioxygenases | 1 | 2015 | 353 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 326 | 0.030 |
Why?
|
Glutarates | 1 | 2014 | 242 | 0.030 |
Why?
|
Fatty Acids | 1 | 2020 | 1806 | 0.020 |
Why?
|
Teratoma | 1 | 2015 | 405 | 0.020 |
Why?
|
Blotting, Western | 2 | 2013 | 5022 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2669 | 0.020 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 83 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 1434 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1163 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1885 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4349 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2045 | 0.020 |
Why?
|
Databases, Factual | 1 | 2006 | 8066 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4276 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2013 | 2881 | 0.020 |
Why?
|
Prognosis | 4 | 2017 | 29948 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2014 | 715 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13485 | 0.020 |
Why?
|
Cell Cycle | 1 | 2018 | 2926 | 0.020 |
Why?
|
Pyridines | 2 | 2014 | 2888 | 0.020 |
Why?
|
Tretinoin | 1 | 2013 | 524 | 0.020 |
Why?
|
Gene Library | 1 | 2013 | 1065 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10745 | 0.020 |
Why?
|
Cell Culture Techniques | 2 | 2008 | 1646 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2467 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6895 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2015 | 1079 | 0.020 |
Why?
|
Thrombocythemia, Essential | 1 | 2010 | 114 | 0.020 |
Why?
|
Sarcoma | 1 | 2020 | 1802 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1996 | 0.020 |
Why?
|
Calcium Channels | 1 | 2013 | 622 | 0.020 |
Why?
|
Amino Acids | 1 | 2015 | 1711 | 0.020 |
Why?
|
Polycythemia Vera | 1 | 2010 | 160 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3401 | 0.020 |
Why?
|
Survival Analysis | 2 | 2017 | 10100 | 0.020 |
Why?
|
Thrombopoiesis | 1 | 2010 | 160 | 0.020 |
Why?
|
Neurogenesis | 1 | 2015 | 862 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2002 | 3989 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2010 | 1141 | 0.020 |
Why?
|
Male | 13 | 2019 | 364142 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 2010 | 209 | 0.020 |
Why?
|
Immunomagnetic Separation | 1 | 2008 | 78 | 0.020 |
Why?
|
3T3 Cells | 1 | 2010 | 1082 | 0.020 |
Why?
|
Receptors, CCR7 | 1 | 2008 | 105 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5199 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1110 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1244 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9320 | 0.020 |
Why?
|
Africa | 1 | 2010 | 726 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3439 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2010 | 1062 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2008 | 20144 | 0.020 |
Why?
|
Oxazines | 1 | 2009 | 358 | 0.020 |
Why?
|
Fluorometry | 1 | 2007 | 99 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2717 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 938 | 0.020 |
Why?
|
Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2002 | 2662 | 0.020 |
Why?
|
Pentacyclic Triterpenes | 1 | 2006 | 36 | 0.020 |
Why?
|
Phenothiazines | 1 | 2006 | 60 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2631 | 0.020 |
Why?
|
Cyclin D | 1 | 2006 | 71 | 0.020 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2006 | 30 | 0.020 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 2006 | 34 | 0.020 |
Why?
|
Morpholines | 1 | 2009 | 584 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4747 | 0.020 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 1 | 2006 | 31 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1762 | 0.020 |
Why?
|
Triterpenes | 1 | 2006 | 78 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2597 | 0.020 |
Why?
|
Metabolomics | 1 | 2015 | 1675 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 384 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4427 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 878 | 0.020 |
Why?
|
Benzoquinones | 1 | 2006 | 198 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2801 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5386 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1647 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 335 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2430 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 381 | 0.020 |
Why?
|
Aminopyridines | 1 | 2009 | 577 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1716 | 0.020 |
Why?
|
Drosophila | 1 | 2013 | 1508 | 0.020 |
Why?
|
E-Box Elements | 1 | 2004 | 21 | 0.020 |
Why?
|
Tyrosine | 1 | 2009 | 1425 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1982 | 0.020 |
Why?
|
gp100 Melanoma Antigen | 1 | 2004 | 37 | 0.020 |
Why?
|
Phenotype | 2 | 2015 | 16724 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1767 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 2006 | 319 | 0.010 |
Why?
|
Molecular Weight | 1 | 2007 | 2168 | 0.010 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2005 | 313 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2391 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 712 | 0.010 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2006 | 429 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2004 | 185 | 0.010 |
Why?
|
MicroRNAs | 1 | 2020 | 3792 | 0.010 |
Why?
|
Child | 2 | 2023 | 80668 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2006 | 1305 | 0.010 |
Why?
|
Drug Synergism | 1 | 2008 | 1756 | 0.010 |
Why?
|
Homeostasis | 1 | 2015 | 3342 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2015 | 2903 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2009 | 838 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2005 | 340 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2030 | 0.010 |
Why?
|
Microspheres | 1 | 2007 | 774 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3609 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3944 | 0.010 |
Why?
|
S Phase | 1 | 2004 | 424 | 0.010 |
Why?
|
Homozygote | 1 | 2008 | 1775 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2009 | 1392 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2005 | 663 | 0.010 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 409 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1882 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2413 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 1197 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 663 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3275 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 594 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2006 | 496 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2010 | 1865 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2006 | 678 | 0.010 |
Why?
|
Genetic Variation | 2 | 2008 | 6612 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1657 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2730 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8507 | 0.010 |
Why?
|
Protein Array Analysis | 1 | 2004 | 399 | 0.010 |
Why?
|
Haplotypes | 1 | 2008 | 2727 | 0.010 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2004 | 856 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2006 | 1057 | 0.010 |
Why?
|
Predictive Value of Tests | 3 | 2002 | 15416 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2826 | 0.010 |
Why?
|
Stem Cells | 1 | 2014 | 3537 | 0.010 |
Why?
|
Melanocytes | 1 | 2004 | 508 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6012 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2015 | 65273 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2004 | 661 | 0.010 |
Why?
|
Enzymes | 1 | 2002 | 254 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2004 | 428 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2002 | 393 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12534 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 1525 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11061 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40149 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3587 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5795 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10264 | 0.010 |
Why?
|
Genome | 1 | 2007 | 1752 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18984 | 0.010 |
Why?
|
Sirolimus | 1 | 2006 | 1540 | 0.010 |
Why?
|
Vincristine | 1 | 2002 | 1039 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1927 | 0.010 |
Why?
|
Dexamethasone | 1 | 2006 | 1962 | 0.010 |
Why?
|
Proteins | 2 | 2004 | 6002 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2002 | 1889 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15835 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 223257 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1966 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4539 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2228 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1560 | 0.010 |
Why?
|
Pyrimidines | 1 | 2009 | 3043 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21525 | 0.010 |
Why?
|
Prednisone | 1 | 2002 | 1566 | 0.010 |
Why?
|
Lung | 1 | 2015 | 10067 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2002 | 2234 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 2210 | 0.010 |
Why?
|
Doxorubicin | 1 | 2002 | 2229 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12415 | 0.010 |
Why?
|
Fibroblasts | 1 | 2004 | 4166 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3702 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7241 | 0.010 |
Why?
|
Adult | 3 | 2020 | 223307 | 0.010 |
Why?
|
Software | 1 | 2006 | 4466 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9461 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2002 | 6850 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2002 | 3314 | 0.010 |
Why?
|
Infant | 1 | 2010 | 36461 | 0.000 |
Why?
|
Insulin | 1 | 2002 | 6608 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4970 | 0.000 |
Why?
|
Aged | 2 | 2015 | 171343 | 0.000 |
Why?
|
Liver | 1 | 2002 | 7571 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23717 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2006 | 8717 | 0.000 |
Why?
|
Obesity | 1 | 2006 | 13090 | 0.000 |
Why?
|
Risk Factors | 1 | 2002 | 74881 | 0.000 |
Why?
|